Main differences between two highly effective lipid-lowering therapies in subclasses of lipoproteins in patients with acute myocardial infarction.
Leticia C S PintoAna P Q MelloMaria C O IzarNagila R T DamascenoAntonio M F NetoCarolina N FrançaAdriano CaixetaHenrique T BiancoRui M S PóvoaFlavio T MoreiraAmanda S F BacchinFrancisco Antônio Helfenstein FonsecaPublished in: Lipids in health and disease (2021)
ClinicalTrials.gov , NCT02428374, registered on 28/09/2014.